not happy, page-51

Thanks for that rusty,

I've been going over the Shareholder Communication Policy again and it is obvious to me that Novogen is working with the assumption that it is a clinical drug company. This assumption is currently false. Novogen has no drugs that are currently in the clinic. Novogen is presently a pre-clinical drug company.

Pre-clinical data is the only data that Novogen currently has and it is the only metric upon which "information that would help a reasonable person to decide ether to acquire, retain or dispose of the Company’s securities" can be obtained. This should be announced to the ASX/NASDAQ



Novogen has committed to following this guide, Code of Best Practice for Reporting by Life Science Companies, which states in the ASX listing rules disclosure section:


I don't think that any reasonable person would put Novogen in the 'mature company' box.

The reality is that pre-clinical data is materially significant for Novogen.